[1]
Bellone, M. et al. 2022. Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis. Farmeconomia. Health economics and therapeutic pathways. 23, 1 (Nov. 2022). DOI:https://doi.org/10.7175/fe.v23i1.1532.